Xinhua News Agency
VLADIVOSTOK — The Russian government will allocate 387 million rubles (about 4.8 million U.S. dollars) to produce Mir-19, a new anti-coronavirus drug developed by Russian scientists.
Russian Prime Minister Mikhail Mishustin signed a decree on the allocation of the funds, the press service of the Cabinet of Ministers said on Sunday (April 10).
The funds will be allocated to the state-owned Institute of Immunology of the Federal Medical and Biological Agency, which is the developer of this drug. The money will be used to upgrade and purchase the necessary equipment.
Mir-19 was registered by the Ministry of Health of Russia on Dec. 22, 2021. The drug can prevent and treat coronavirus infection via pulmonary or intranasal administration.
It stops the virus from replicating and prevents the most severe forms of the disease, as well as pneumonitis and acute respiratory distress syndromes.
